MediWound (MDWD) Treasury Shares (2013 - 2014)

MediWound (MDWD) posted quarterly Treasury Shares of -$34.6 million for Q1 2014, little changed quarter-over-quarter from -$34.6 million in Q4 2013.

MediWound (MDWD) Treasury Shares (2013 - 2014) Analysis & Trends

MediWound's Treasury Shares history runs 2 years deep, the most recent figure standing at -$34.6 million for Q1 2014.

In Q1 2014, Treasury Shares changed N/A year-over-year to -$34.6 million; the TTM figure through Mar 2014 stood at -$34.6 million (changed N/A YoY), while the FY2013 annual figure was -$34.6 million, changed N/A from the prior year.
Treasury Shares for Q1 2014 stood at -$34.6 million, roughly flat from -$34.6 million in the prior quarter.
The five-year high for Treasury Shares was -$34.6 million in Q3 2013, with the low at -$34.6 million in Q3 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	MediWound	170.65 Mn	139.65 Mn	337,000.00	-

Download Data